The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 22, 2016

Filed:

Apr. 03, 2013
Applicants:

Nitto Denko Corporation, Osaka, JP;

Osaka University, Osaka, JP;

Inventors:

Masahiro Fukasaka, Osaka, JP;

Arimichi Okazaki, Osaka, JP;

Daisuke Asari, Osaka, JP;

Mitsuhiko Hori, Osaka, JP;

Shizuo Akira, Osaka, JP;

Osamu Takeuchi, Osaka, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/39 (2006.01); A61K 39/145 (2006.01); A61K 39/12 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 39/12 (2013.01); A61K 39/145 (2013.01); A61K 2039/5252 (2013.01); A61K 2039/541 (2013.01); A61K 2039/542 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/55572 (2013.01); A61K 2039/575 (2013.01); C12N 2710/00034 (2013.01); C12N 2760/16034 (2013.01); C12N 2760/16134 (2013.01);
Abstract

An intraorally administrable vaccine composition useful to be a preventive or therapeutic agent for infectious diseases, and effectively induces a systemic immune response or a mucosal immune response is provided. A vaccine composition for administration to the oral cavity of a human or an animal, the vaccine composition containing at least one antigen derived from an infectious disease, and at least one selected from the group consisting of a toll-like receptor 4 (TLR4) agonist, a toll-like receptor 2/6 (TLR2/6) agonist, and cyclic dinucleotide, or a derivative or salt thereof.


Find Patent Forward Citations

Loading…